SCM
GSK icon

Stonebridge Capital Management’s GSK GSK Stock Holding History

Stonebridge Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$200K Hold
5,203
– – 0.08% 84
2025
Q1 		$202K Buy
+5,203
New +$190K 0.09% 83
2024
Q4 		– Sell
-5,203
Closed -$213K – 82
2024
Q3 		$213K Sell
5,203
-80
-2% -$3.27K 0.08% 79
2024
Q2 		$203K Hold
5,283
– – 0.09% 80
2024
Q1 		$226K Sell
5,283
-200
-4% -$8.25K 0.1% 72
2023
Q4 		$203K Buy
+5,483
New +$197K 0.1% 75
2023
Q1 		– Sell
-8,243
Closed -$290K – 90
2022
Q4 		$290K Sell
8,243
-680
-8% -$22.6K 0.14% 81
2022
Q3 		$263K Hold
8,923
– – 0.14% 82
2022
Q2 		$486K Hold
8,923
– – 0.22% 64
2022
Q1 		$486K Hold
8,923
– – 0.18% 69
2021
Q4 		$492K Sell
8,923
-80
-0.9% -$4.16K 0.17% 71
2021
Q3 		$430K Sell
9,003
-480
-5% -$24.1K 0.16% 72
2021
Q2 		$472K Buy
9,483
+920
+11% +$44.2K 0.17% 72
2021
Q1 		$382K Buy
8,563
+320
+4% +$14.5K 0.15% 74
2020
Q4 		$379K Hold
8,243
– – 0.16% 72
2020
Q3 		$388K Hold
8,243
– – 0.18% 65
2020
Q2 		$421K Sell
8,243
-600
-7% -$30.8K 0.22% 62
2020
Q1 		$419K Sell
8,843
-1,400
-14% -$74.7K 0.23% 65
2019
Q4 		$602K Buy
10,243
+80
+0.8% +$4.45K 0.26% 60
2019
Q3 		$542K Sell
10,163
-1,880
-16% -$96.7K 0.25% 65
2019
Q2 		$602K Sell
12,043
-3,320
-22% -$167K 0.24% 68
2019
Q1 		$802K Sell
15,363
-4,640
-23% -$232K 0.29% 67
2018
Q4 		$955K Buy
20,003
+3,440
+21% +$169K 0.38% 60
2018
Q3 		$832K Sell
16,563
-820
-5% -$41.7K 0.29% 65
2018
Q2 		$885K Buy
17,383
+357
+2% +$18K 0.32% 65
2018
Q1 		$864K Buy
+17,026
New +$793K 0.32% 63

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Stonebridge Capital Management's GSK Position: Q2 2025 in Review

Stonebridge Capital Management held its GSK (GSK) position steady in Q2 2025 at 5,203 shares worth $200K. The position accounts for 0.08% of the portfolio, ranked #84.

Stonebridge Capital Management first reported a position in GSK in Q1 2018 and has held it in 26 quarters since. The position peaked at $955K in Q4 2018. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

  • Stonebridge Capital Management held 5,203 shares of GSK worth $200K as of Q2 2025.
  • Stonebridge Capital Management left its GSK share count unchanged in Q2 2025.
  • GSK made up 0.08% of Stonebridge Capital Management's portfolio in Q2 2025, its #84 holding.
  • Stonebridge Capital Management first reported a position in GSK in Q1 2018 and has held it in 26 quarters since.
  • Stonebridge Capital Management's GSK position peaked at $955K in Q4 2018.
  • 890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Stonebridge Capital Management's 13F filing for Q2 2025, filed 1 Jul 2025.